Association between miR34b/c polymorphism rs4938723 and cancer risk: A meta-analysis of 11 studies including 6169 cases and 6337 controls

Medical Science Monitor

Volumn 20, Issue , 2014, Pages 1977-1982

  Wang, Xinjing ^a   Lu, Xiongxiong ^a   Fang, Yuan ^a   Chen, Hao ^a   Deng, Xiaxing ^a   Peng, Chenghong ^a   Li, Hongwei ^a   Shen, Baiyong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Genes, Neoplasm; Meta analysis; MicroRNAs; Polymorphism, Genetic

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CODOMINANCE; COLORECTAL CANCER; DNA POLYMORPHISM; HUMAN; LIVER CELL CARCINOMA; META ANALYSIS; NASOPHARYNX CANCER; OSTEOSARCOMA; PUBLISHING; RENAL CANCER CELL LINE; SENSITIVITY ANALYSIS; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETICS; NEOPLASM;

MICRORNA; MIRN34 MICRORNA, HUMAN;

CASE-CONTROL STUDIES; HUMANS; MICRORNAS; NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 84908139400     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.892350     Document Type: Article

References (33)

1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. Cancer J Clin, 2013; 63: 11-30
2. Zhao P, Dai M, Chen W et al: Cancer trends in China. Jpn J Clin Oncol, 2010; 40: 281-85
3. Jemal A, Bray F, Center AA et al: Global cancer statistics. Cancer J Clin, 2011; 61: 69-90
4. Dong J, Sui L, Wang Q et al: MicroRNA-26a inhibits cell proliferation and invasion of cervical cancer cells by targeting protein tyrosine phosphatase type IVA1. Mol Med Rep, 2014; 10(3): 1426-32
5. Babashah S, Soleimani M: The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Eur J Cancer, 2011; 47: 1127-37
6. Niu H, Wang K, Zhang A et al: MiR-92a is a critical regulator of the apoptosis pathway in glioblastoma with inverse expression of BCL2L11. Oncol Rep, 2012; 28: 1771-77
7. Ren Y, Han X, Yu K et al: MicroRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer cells. Mol Med Rep, 2014; 10: 315-21
8. Wang XH, Cai P, Wang MH et al: MicroRNA25 promotes osteosarcoma cell proliferation by targeting the cellcycle inhibitor p27. Mol Med Rep, 2014; 10: 855-59
9. Bensen JT, Tse CK, Nyante SJ et al: Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study. Cancer Causes Control, 2013; 24: 1099-109
10. Zhang S, Qian J, Cao Q et al: A potentially functional polymorphism in the promoter region of miR-34b/c is associated with renal cell cancer risk in a Chinese population. Mutagenesis, 2014; 29: 149-54
11. Gao LB, Li LJ, Pan XM et al: A genetic variant in the promoter region of miR-34b/c is associated with a reduced risk of colorectal cancer. Biol Chem, 2013; 394: 415-20
12. Han Y, Pu R, Han X et al: Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk. PLoS One, 2013; 8: e58564
13. Li L, Wu J, Sima X et al: Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma. Tumour Biol, 2013; 34: 1919-23
14. Oh J, Kim JW, Lee BE et al: Polymorphisms of the pri-miR-34b/c promoter and TP53 codon 72 are associated with risk of colorectal cancer. Oncol Rep, 2014; 31: 995-1002
15. Son MS, Jang MJ, Jeon YJ et al: Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma. Gene, 2013; 524: 156-60
16. Tian Q, Jia J, Ling S et al: A causal role for circulating miR-34b in osteosarcoma. Eur J Surg Oncol, 2014; 40: 67-72
17. Xu Y, Liu L, Liu J et al: A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer, 2011; 128: 412-17
18. Yin J, Wang X, Zheng L et al: Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population. PLoS One, 2013; 8: e80570
19. Egger M, Davey Smith G, Schneider M et al: Bias in meta-analysis detected by a simple, graphical test. BMJ, 1997; 315: 629-34
20. Lau J, Ioannidis JP, Schmid CH: Quantitative synthesis in systematic reviews. Ann Intern Med, 1997; 127: 820-26
21. Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics, 1994; 50: 1088-101
22. Chang TC, Wentzel EA, Kent OA et al: Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell, 2007; 26: 745-52
23. He L, He X, Lim LP et al: A microRNA component of the p53 tumour suppressor network. Nature, 2007; 447: 1130-34
24. Corney DC, Flesken-Nikitin A, Godwin AK et al: MicroRNA-34b and MicroRNA- 34c are targets of p53 and cooperate in control of cell proliferation and adhesion- independent growth. Cancer Res, 2007; 67: 8433-38
25. Wong MY, Yu Y, Walsh WR et al: MicroRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review). Int J Oncol, 2011; 38: 1189-95
26. Tarasov V, Jung P, Verdoodt B et al: Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle, 2007; 6: 1586-93
27. Tanaka N, Toyooka S, Soh J et al: Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells. Oncol Rep, 2013; 29: 2169-74
28. Tamura M, Uyama M, Sugiyama Y et al: Canonical Wnt signaling activates miR-34 expression during osteoblastic differentiation. Mol Med Rep, 2013; 8: 1807-11
29. Ji Q, Hao X, Zhang M et al: MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One, 2009; 4: e6816
30. Ji Q, Hao X, Meng Y et al: Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer, 2008; 8: 266
31. Corney DC, Hwang CI, Matoso A et al: Frequent downregulation of miR-34 family in human ovarian cancers. Clin Cancer Res, 2010; 16: 1119-28
32. Cheng CY, Hwang CI, Corney DC et al: miR-34 cooperates with p53 in suppression of prostate cancer by joint regulation of stem cell compartment. Cell Rep, 2014; 6: 1000-7
33. Liang TJ, Liu HJ, Zhao XQ et al: Lack of association of MiR-34b/c polymorphism (rs4938723) with hepatocellular carcinoma: a meta-analysis. PLoS One, 2013; 8: e68588